Literature DB >> 17920902

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis.

Sriram Venneti1, Guoji Wang, Clayton A Wiley.   

Abstract

HIV encephalitis (HIVE) is characterized by neurodegeneration mediated by toxins derived from infected and activated brain macrophages. Since the peripheral benzodiazepine receptor (PBR) is abundant on brain macrophages, we hypothesized that [(3)H]DAA1106, a new PBR ligand, can label infected and activated brain macrophages in HIVE. Using cell culture and postmortem brain tissues from HIVE and a macaque model of HIVE, we show that [(3)H]DAA1106 binds with high affinity to activated and infected macrophages in regions of synaptic damage. Further, binding affinity reflected by lower K(D) (dissociation constant) values and the B(max) (total number of binding sites) to K(D) ratios reflective of ligand-binding potential was significantly higher with [(3)H]DAA1106 compared to the extensively characterized PBR ligand [(3)H](R)-PK11195. These data suggest that DAA1106 binds with high affinity to activated and infected brain macrophages and possesses binding characteristics beneficial for in vivo use in the detection and clinical monitoring of HIVE using positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920902      PMCID: PMC2258458          DOI: 10.1016/j.nbd.2007.08.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

1.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195.

Authors:  S Pappata; M Levasseur; R N Gunn; R Myers; C Crouzel; A Syrota; T Jones; G W Kreutzberg; R B Banati
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

2.  An efficient method for the culturing and generation of neurons and astrocytes from second trimester human central nervous system tissue.

Authors:  K Barami; W E Grever; F G Diaz; W D Lyman
Journal:  Neurol Res       Date:  2001-06       Impact factor: 2.448

Review 3.  Neurological manifestations of HIV-1 infection in the HAART era.

Authors:  A P Geraci; D M Simpson
Journal:  Compr Ther       Date:  2001

4.  Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity.

Authors:  A C Kuhlmann; T R Guilarte
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

Review 5.  HIV and antiretroviral therapy in the brain: neuronal injury and repair.

Authors:  Ronald Ellis; Dianne Langford; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

6.  In-vivo measurement of activated microglia in dementia.

Authors:  A Cagnin; D J Brooks; A M Kennedy; R N Gunn; R Myers; F E Turkheimer; T Jones; R B Banati
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

Review 7.  Peripheral benzodiazepine receptors and mitochondrial function.

Authors:  Pierre Casellas; Sylvaine Galiegue; Anthony S Basile
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

Review 8.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

Review 9.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

10.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Authors:  R B Banati; J Newcombe; R N Gunn; A Cagnin; F Turkheimer; F Heppner; G Price; F Wegner; G Giovannoni; D H Miller; G D Perkin; T Smith; A K Hewson; G Bydder; G W Kreutzberg; T Jones; M L Cuzner; R Myers
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

View more
  14 in total

1.  Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Authors:  Junchao Tong; Belinda Williams; Pablo M Rusjan; Romina Mizrahi; Jean-Jacques Lacapère; Tina McCluskey; Yoshiaki Furukawa; Mark Guttman; Lee-Cyn Ang; Isabelle Boileau; Jeffrey H Meyer; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

Review 2.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

Review 3.  Molecular imaging of microglia/macrophages in the brain.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Glia       Date:  2012-05-21       Impact factor: 7.452

4.  The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.

Authors:  Sriram Venneti; Guoji Wang; Jason Nguyen; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

5.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

6.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

7.  Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Authors:  Clayton A Wiley; Brian J Lopresti; Sriram Venneti; Julie Price; William E Klunk; Steven T DeKosky; Chester A Mathis
Journal:  Arch Neurol       Date:  2009-01

9.  [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration.

Authors:  Tatiana Rodríguez-Chinchilla; Ana Quiroga-Varela; Francisco Molinet-Dronda; Arantzazu Belloso-Iguerategui; Leyre Merino-Galan; Haritz Jimenez-Urbieta; Belén Gago; María Cruz Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-23       Impact factor: 9.236

10.  Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.

Authors:  J L E Bird; D Izquierdo-Garcia; J R Davies; J H F Rudd; K C Probst; N Figg; J C Clark; P L Weissberg; A P Davenport; E A Warburton
Journal:  Atherosclerosis       Date:  2009-12-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.